These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
440 related items for PubMed ID: 8463441
1. Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects. Berlin I, Warot D, Hergueta T, Molinier P, Bagot C, Puech AJ. J Clin Psychopharmacol; 1993 Apr; 13(2):100-6. PubMed ID: 8463441 [Abstract] [Full Text] [Related]
2. A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers. Blin O, Micallef J, Audebert C, Legangneux E. J Clin Psychopharmacol; 2006 Jun; 26(3):284-9. PubMed ID: 16702893 [Abstract] [Full Text] [Related]
3. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability. Evans SM, Funderburk FR, Griffiths RR. J Pharmacol Exp Ther; 1990 Dec; 255(3):1246-55. PubMed ID: 2262904 [Abstract] [Full Text] [Related]
4. Residual effects of zolpidem, triazolam, rilmazafone and placebo in healthy elderly subjects: a randomized double-blind study. Uemura SI, Kanbayashi T, Wakasa M, Satake M, Ito W, Shimizu K, Shioya T, Shimizu T, Nishino S. Sleep Med; 2015 Nov; 16(11):1395-1402. PubMed ID: 26498242 [Abstract] [Full Text] [Related]
5. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans. Rush CR, Madakasira S, Goldman NH, Woolverton WL, Rowlett JK. J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195 [Abstract] [Full Text] [Related]
6. Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance. Troy SM, Lucki I, Unruh MA, Cevallos WH, Leister CA, Martin PT, Furlan PM, Mangano R. J Clin Psychopharmacol; 2000 Jun; 20(3):328-37. PubMed ID: 10831020 [Abstract] [Full Text] [Related]
7. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers. Hallam KT, Olver JS, McGrath C, Norman TR. Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021 [Abstract] [Full Text] [Related]
8. Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences. Greenblatt DJ, Harmatz JS, von Moltke LL, Wright CE, Durol AL, Harrel-Joseph LM, Shader RI. J Pharmacol Exp Ther; 2000 May; 293(2):435-43. PubMed ID: 10773013 [Abstract] [Full Text] [Related]
13. Temporal changes in postural sway caused by ultrashort-acting hypnotics: triazolam and zolpidem. Nakamura M, Ishii M, Niwa Y, Yamazaki M, Ito H. ORL J Otorhinolaryngol Relat Spec; 2005 Nov; 67(2):106-12. PubMed ID: 15821354 [Abstract] [Full Text] [Related]
17. Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory. Mattila MJ, Vanakoski J, Kalska H, Seppälä T. Pharmacol Biochem Behav; 1998 Apr; 59(4):917-23. PubMed ID: 9586849 [Abstract] [Full Text] [Related]
18. Effects of daytime administration of zolpidem versus triazolam on memory. Wesensten NJ, Balkin TJ, Belenky GL. Eur J Clin Pharmacol; 1995 Apr; 48(2):115-22. PubMed ID: 7589024 [Abstract] [Full Text] [Related]
19. Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers. Rush CR, Griffiths RR. J Clin Psychopharmacol; 1996 Apr; 16(2):146-57. PubMed ID: 8690830 [Abstract] [Full Text] [Related]
20. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects. Johnson MW, Suess PE, Griffiths RR. Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817 [Abstract] [Full Text] [Related] Page: [Next] [New Search]